131 related articles for article (PubMed ID: 3221917)
21. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
[TBL] [Abstract][Full Text] [Related]
22. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen.
Stein R; Chen S; Grossman W; Goldenberg DM
Cancer Res; 1989 Jan; 49(1):32-7. PubMed ID: 2461799
[TBL] [Abstract][Full Text] [Related]
23. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
Sasaki K
Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
[TBL] [Abstract][Full Text] [Related]
24. Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines.
Wolf MF; Koerner U; Schumacher K
Cancer Res; 1986 Apr; 46(4 Pt 1):1779-82. PubMed ID: 2418954
[TBL] [Abstract][Full Text] [Related]
25. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry.
Yuan M; Itzkowitz SH; Boland CR; Kim YD; Tomita JT; Palekar A; Bennington JL; Trump BF; Kim YS
Cancer Res; 1986 Sep; 46(9):4841-7. PubMed ID: 3731131
[TBL] [Abstract][Full Text] [Related]
26. Thomsen-Friedenreich-related antigen in human endometrium. An immunohistochemical study employing the monoclonal antibody 49H.8. A preliminary report.
Ravn V; Jensen H
APMIS; 1988 Jun; 96(6):552-8. PubMed ID: 3293628
[TBL] [Abstract][Full Text] [Related]
27. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
[No Abstract] [Full Text] [Related]
28. The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
Dippold W; Steinborn A; Meyer zum Büschenfelde KH
Environ Health Perspect; 1990 Aug; 88():255-7. PubMed ID: 2272320
[TBL] [Abstract][Full Text] [Related]
29. Blood group Tn-active macromolecules from human carcinomas and erythrocytes: characterization of and specific reactivity with mono- and poly-clonal anti-Tn antibodies induced by various immunogens.
Springer GF; Chandrasekaran EV; Desai PR; Tegtmeyer H
Carbohydr Res; 1988 Jul; 178():271-92. PubMed ID: 3056614
[TBL] [Abstract][Full Text] [Related]
30. [Different expressions of various epitopes of the Thomsen-Friedenreich antigen in breast cancer cells. Immunohistochemical study with monoclonal antibodies against asialoglycophorin A].
Bein G; Poschmann A; Seitz RC; Böcker W
Verh Dtsch Ges Pathol; 1985; 69():218-21. PubMed ID: 2420088
[No Abstract] [Full Text] [Related]
31. Analysis of human tumor associated Thomsen-Friedenreich antigen.
Samuel J; Noujaim AA; MacLean GD; Suresh MR; Longenecker BM
Cancer Res; 1990 Aug; 50(15):4801-8. PubMed ID: 2196117
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of the cancer associated antigens T (Thomsen-Friedenreich) and Tn to the skin in primary and metastatic carcinomas.
Kanitakis J; al-Rifai I; Faure M; Claudy A
J Clin Pathol; 1998 Aug; 51(8):588-92. PubMed ID: 9828816
[TBL] [Abstract][Full Text] [Related]
33. Thomsen-Friedenreich antigen: the "hidden" tumor antigen.
Goletz S; Cao Y; Danielczyk A; Ravn P; Schoeber U; Karsten U
Adv Exp Med Biol; 2003; 535():147-62. PubMed ID: 14714894
[No Abstract] [Full Text] [Related]
34. Studies on the Thomsen-Friedenreich antigen in human colon with the lectin Amaranthin. Normal and neoplastic epithelium express only cryptic T antigen.
Sata T; Roth J; Zuber C; Stamm B; Rinderle SJ; Goldstein IJ; Heitz PU
Lab Invest; 1992 Feb; 66(2):175-86. PubMed ID: 1370965
[TBL] [Abstract][Full Text] [Related]
35. Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma.
Takanami I
Oncol Rep; 1999; 6(2):341-4. PubMed ID: 10023001
[TBL] [Abstract][Full Text] [Related]
36. [Carcinoma in situ of the urinary bladder: clinical experience and preliminary study of Thomsen-Friedenreich antigen].
Sasaki K; Maru A; Sakashita S; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1984 Feb; 75(2):269-77. PubMed ID: 6379252
[No Abstract] [Full Text] [Related]
37. Monoclonal antibodies directed to the blood group A associated structure, galactosyl-A: specificity and relation to the Thomsen-Friedenreich antigen.
Clausen H; Stroud M; Parker J; Springer G; Hakomori S
Mol Immunol; 1988 Feb; 25(2):199-204. PubMed ID: 3287140
[TBL] [Abstract][Full Text] [Related]
38. Thomsen-Friedenreich antigen in bladder cancer tissues detected by monoclonal antibody.
Yokoyama M; Ohoka H; Oda H; Oda T; Utsumi S; Takeuchi M
Hinyokika Kiyo; 1988 Feb; 34(2):255-8. PubMed ID: 3376817
[TBL] [Abstract][Full Text] [Related]
39. T antigen expression in benign hyperplasia and adenocarcinoma of the prostate.
Moriyama H; Nakano H; Igawa M; Nihira H
Urol Int; 1987; 42(2):120-3. PubMed ID: 2441505
[TBL] [Abstract][Full Text] [Related]
40. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
Yamada T; Fukui I; Yokogawa M; Oshima H
Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
